Medindia
Medindia LOGIN REGISTER
Advertisement

JumpStart Invests in Tursiop Technologies

Friday, June 20, 2008 General News
Advertisement
CLEVELAND, June 19 JumpStart Inc., the Northeast Ohioventure development organization that accelerates the growth of innovativeearly-stage businesses and ideas, has announced an investment commitment of$350,000 in Cleveland-based Tursiop Technologies, LLC. The JumpStartinvestment is part of a recently closed investment round that included $1million from RMS Management of Cleveland, OH.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )

Tursiop is developing a novel nanomaterial-based coil for magneticresonance scanners. This new type of coil will bring fundamental change to theMRI market through its improved image quality, compared to conventional coiltechnologies. Targeting a projected billion dollar market by 2012, Tursiop hasalready built, tested, and generated images with several prototype coils.These coils have outperformed conventional coils and the Tursiop team,including CEO Brad Goldstein, believes that with additional developmentfurther significant gains will be achieved.
Advertisement

"Our patent-pending technology is based on a fundamental change in the waythe coils are designed and manufactured," said Goldstein. "We at Tursiop areexcited to be at the nexus of medical imaging and nanotechnology and lookforward to providing clinicians the means to enhance the diagnosis andtreatment of some of the major health concerns of our time, including heartdisease, neurological disorders, and cancer."

JumpStart Entrepreneur-in-Residence Kevin Mendelsohn will be working withthe company. "MRI scanners and coils are mature technologies that haveexperienced only incremental change over the past 10 to 15 years," Mendelsohnsaid. "Currently, the most effective method of improving image quality isthrough increased magnet strength, which is a costly alternative. The other isthrough the use of specialty coils, but when compared to increased magnetstrength, the improvement has been relatively small. Tursiop's coils offerimproved imaging performance comparable to that of a more powerful scanner,but at a much lower cost," he concluded.

With the close of this investment round, Tursiop plans to establish officeand laboratory spaces, continue research and product development, and beginthe FDA approval process.

This is JumpStart's 41st investment in its 30th company. Other healthcarecompanies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx,CardioInsight Technologies, CerviLenz, Great Lakes Pharmaceuticals, SynapseBiomedical and Telerad Express.

About Tursiop Technologies, LLC

Tursiop Technologies is developing revolutionary MRI coil devicesutilizing proprietary nanotechnology, which will produce higher image qualityand faster scan times resulting in a significant boost of the functionalcapabilities of any installed MRI system. Tursiop-generated imagingenhancements will apply across the entire range of MRI system field strengths,from low-field to high-field systems. Increased diagnostic competency willlead to improved patient outcomes and open the doors to new therapeuticopportunities within the areas of interventional, intra-operative andfunctional MRI and molecular imaging.

About RMS Management

RMS Management is an integrated family office that was formed in 1991 andis comprised of a diverse group of individuals and institutions providingfinancial and personal services to the founding families of a publicly tradedreal estate company. The company strives to enhance the professional andpersonal goals and objectives of every generation of the Ratner, Miller andShafran families.

About JumpStart Inc.

JumpStart ( www.jumpstartinc.org ) accelerates the growth of innovativeearly-stage businesses and ideas into venture-ready companies by deliveringvital, focused resources to entrepreneurs and the community of Northeast Ohio.JumpStart identifies and invests in early
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close